1 / 6

Creating a Surveillance System to Track and Measure Consumer Demand

Creating a Surveillance System to Track and Measure Consumer Demand . Tracy Orleans representing Cathy Backinger, Gary Giovino, Ann Malarcher, John Pinney (Joe Gitchell), Dawn Robbins and Susan Swartz . Purpose of Breakthrough Group. Aims were to:

talor
Download Presentation

Creating a Surveillance System to Track and Measure Consumer Demand

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Creating a Surveillance System to Track and Measure Consumer Demand Tracy Orleans representing Cathy Backinger, Gary Giovino, Ann Malarcher, John Pinney (Joe Gitchell), Dawn Robbins and Susan Swartz

  2. Purpose of Breakthrough Group • Aims were to: • (1) review the major gaps in current epidemiologic surveillance of quitting behaviors, treatment use, determinants (coverage, promotion, other policies) and outcomes (health/cost) of treatment use, and • (2) begin to identify feasible strategies for addressing those gaps. One strategy this group discussed was adoption of a minimum core dataset to measure quitting motivation and behavior including use of proven treatments. Another was the creation of a longitudinal database with the ability to “track the journey” beyond current annual indicators of tobacco use and cessation.

  3. Breakthrough GroupAction Steps • Dawn Robbins drafted an excellent white paper on current surveillance of tobacco use cessation and insurance coverage. Refined and expanded, this paper is suitable for publication! • Anne Malarcher and Angela Trosclair at CDC complied a list of measures re: adult quitting behavior/treatment use from the ATS, AUTS, BRFSS, CPS-TUS, NHIS, NHANES and PRAMS and teen quitting/treatment use from the MTF, NYTS, YTS and YRBS. This effort revealed current wide variation in measures, and prospects for a core dataset, and identified the CPS as a promising surveillance tool going forward.

  4. Breakthrough GroupAction Steps • Ann Malarcher proposed/circulated the logic model for tobacco cessation from the CDC’s Key Indicators Report as a possible framework for a surveillance system to track and measure consumer demand for and use of proven treatments. • Linda Bailey forwarded information re: the NAQC’s minimal dataset • The group discussed: • the need for a formal systematic “gaps” analysis • the creative use of pharmacy and pharmaceutical sales data • recent NCI efforts to create a national cessation surveillance system; • the formation of an ongoing NSF-funded “Tobacco Surveillance Network”; • several proposals and opportunities for a practical public/private funded longitudinal cohort study on quit attempts, treatment use/coverage and determinants and outcomes of both (e.g., Zeger & Samet; Robert West).

  5. Key Opportunities for Innovation (1) refine and expand Dawn Robbins’ paper as a blueprint for improved surveillance (2) work with NCI and/or the NSF’s Tobacco Surveillance Network to formally analyze and report on surveillance gaps; (3) examine potential for an annual national quitting and treatment use “report card” (4) explore opportunities to design/fund a longitudinal cohort study of quitting motivation and behavior, treatment beliefs, demand, use, cost and benefits as a tool for advocacy and research; and (5) explore opportunities for funding secondary data analysis projects to the individual, product- , systems- and policy- related determinants of, interventions for, and health/economic impacts of improved treatment use. (RWJF’s SAPRP program has taken an initial modest step towards providing such funding.)

  6. Reaching Disparate Populations • The activities described above will clarify the extent and causes of current income, education and racial/ethnic disparities in treatment use and access, and help to identify remedial interventions.

More Related